Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Nature ; 431(7005): 191-5, 2004 Sep 09.
Article in English | MEDLINE | ID: mdl-15356632

ABSTRACT

Nerve impulses are propagated at nodes of Ranvier in the myelinated nerves of vertebrates. Internodal distances have been proposed to affect the velocity of nerve impulse conduction; however, direct evidence is lacking, and the cellular mechanisms that might regulate the length of the myelinated segments are unknown. Ramón y Cajal described longitudinal and transverse bands of cytoplasm or trabeculae in internodal Schwann cells and suggested that they had a nutritive function. Here we show that internodal growth in wild-type nerves is precisely matched to nerve extension, but disruption of the cytoplasmic bands in Periaxin-null mice impairs Schwann cell elongation during nerve growth. By contrast, myelination proceeds normally. The capacity of wild-type and mutant Schwann cells to elongate is cell-autonomous, indicating that passive stretching can account for the lengthening of the internode during limb growth. As predicted on theoretical grounds, decreased internodal distances strikingly decrease conduction velocities and so affect motor function. We propose that microtubule-based transport in the longitudinal bands of Cajal permits internodal Schwann cells to lengthen in response to axonal growth, thus ensuring rapid nerve impulse transmission.


Subject(s)
Nerve Fibers, Myelinated/physiology , Schwann Cells/cytology , Schwann Cells/physiology , Synaptic Transmission/physiology , Animals , Axons/physiology , Behavior, Animal/physiology , Cell Size , Cytoplasm/metabolism , Gene Deletion , Membrane Proteins/deficiency , Membrane Proteins/genetics , Mice , Mice, Knockout , Microtubules/metabolism , Muscle, Skeletal/innervation , Myelin Basic Protein/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , Sciatic Nerve/cytology , Sciatic Nerve/physiology
2.
Neuron ; 48(5): 737-42, 2005 Dec 08.
Article in English | MEDLINE | ID: mdl-16337912

ABSTRACT

Voltage-gated sodium channels are concentrated in myelinated nerves at the nodes of Ranvier flanked by paranodal axoglial junctions. Establishment of these essential nodal and paranodal domains is determined by myelin-forming glia, but the mechanisms are not clear. Here, we show that two isoforms of Neurofascin, Nfasc155 in glia and Nfasc186 in neurons, are required for the assembly of these specialized domains. In Neurofascin-null mice, neither paranodal adhesion junctions nor nodal complexes are formed. Transgenic expression of Nfasc155 in the myelinating glia of Nfasc-/- nerves rescues the axoglial adhesion complex by recruiting the axonal proteins Caspr and Contactin to the paranodes. However, in the absence of Nfasc186, sodium channels remain diffusely distributed along the axon. Our study shows that the two major Neurofascins play essential roles in assembling the nodal and paranodal domains of myelinated axons; therefore, they are essential for the transition to saltatory conduction in developing vertebrate nerves.


Subject(s)
Axons/physiology , Cell Adhesion Molecules/physiology , Nerve Growth Factors/physiology , Neural Conduction/physiology , Sodium Channels/physiology , Animals , Cell Adhesion Molecules/chemistry , Cell Adhesion Molecules/deficiency , Cell Adhesion Molecules/genetics , Extracellular Space , Intercellular Junctions/physiology , Mice , Mice, Knockout/genetics , Mice, Transgenic , Myelin Sheath/metabolism , Nerve Fibers, Myelinated/physiology , Nerve Growth Factors/chemistry , Nerve Growth Factors/deficiency , Nerve Growth Factors/genetics , Neuroglia/metabolism , Neuroglia/physiology , Phenotype , Protein Isoforms/deficiency , Protein Isoforms/genetics , Protein Isoforms/physiology , Protein Structure, Tertiary/physiology , Ranvier's Nodes/physiology
3.
Curr Biol ; 16(16): 1591-605, 2006 Aug 22.
Article in English | MEDLINE | ID: mdl-16920620

ABSTRACT

BACKGROUND: Chronic established pain, especially that following nerve injury, is difficult to treat and represents a largely unmet therapeutic need. New insights are urgently required, and we reasoned that endogenous processes such as cooling-induced analgesia may point the way to novel strategies for intervention. Molecular receptors for cooling have been identified in sensory nerves, and we demonstrate here how activation of one of these, TRPM8, produces profound, mechanistically novel analgesia in chronic pain states. RESULTS: We show that activation of TRPM8 in a subpopulation of sensory afferents (by either cutaneous or intrathecal application of specific pharmacological agents or by modest cooling) elicits analgesia in neuropathic and other chronic pain models in rats, thereby inhibiting the characteristic sensitization of dorsal-horn neurons and behavioral-reflex facilitation. TRPM8 expression was increased in a subset of sensory neurons after nerve injury. The essential role of TRPM8 in suppression of sensitized pain responses was corroborated by specific knockdown of its expression after intrathecal application of an antisense oligonucleotide. We further show that the analgesic effect of TRPM8 activation is centrally mediated and relies on Group II/III metabotropic glutamate receptors (mGluRs), but not opioid receptors. We propose a scheme in which Group II/III mGluRs would respond to glutamate released from TRPM8-containing afferents to exert an inhibitory gate control over nociceptive inputs. CONCLUSIONS: TRPM8 and its central downstream mediators, as elements of endogenous-cooling-induced analgesia, represent a novel analgesic axis that can be exploited in chronic sensitized pain states.


Subject(s)
Analgesia/methods , Cold Temperature , Neuralgia/metabolism , Neuralgia/therapy , TRPM Cation Channels/metabolism , Acrolein/analogs & derivatives , Acrolein/pharmacology , Amino Acids/pharmacology , Analysis of Variance , Animals , Blotting, Western , Dose-Response Relationship, Drug , Electrophysiology , Immunohistochemistry , Male , Menthol/pharmacology , Neuralgia/drug therapy , Oligonucleotides, Antisense , Pyrimidinones/pharmacology , Rats , Rats, Wistar , Receptors, Glutamate/metabolism , Reflex/drug effects , Xanthenes/pharmacology
4.
J Neurosci ; 23(8): 3221-33, 2003 Apr 15.
Article in English | MEDLINE | ID: mdl-12716929

ABSTRACT

Demyelinating diseases can be associated with painful sensory phenomena such as tactile allodynia and hyperalgesia. To study the mechanisms underlying demyelination-induced pain, we have characterized a novel model of demyelination of the sciatic or saphenous nerve. Topical lysolecithin application causes focal demyelination of afferent nerve A-fibers without axonal loss, as assessed either by electron and light microscopy or by immunohistochemical analysis of dorsal root ganglia (DRG) for a neuronal injury marker, activating transcription factor 3. Focal demyelination is accompanied by spontaneous action potentials in afferents and increased expression of neuropeptide Y and Na(v)1.3 sodium channels specifically in DRG neurons that coexpress a specific marker of myelinated afferents. In contrast, expression of tetrodotoxin-resistant, Na(v)1.8 sodium channels is specifically decreased in the same subgroup of DRG cells. Central sensitization of somatosensory processing is also induced, with increased behavioral reflex responsiveness to thermal and mechanical stimuli. These changes are reversed by intrathecal administration of an NMDA receptor antagonist or cannabinoid (CB) receptor agonist, but not by a mu-opioid receptor agonist. Recovery of behavioral reflexes occurred approximately 3 weeks after lysolecithin treatment. This is the first time that demyelination of afferent A-fibers has been shown to specifically induce neuropathic pain and indicates that axonal damage is not a prerequisite for development of the pain state. The profile of phenotypic changes in DRG is distinct from other pain models and displays a sensitivity to NMDA and CB receptor agents that may be exploitable therapeutically.


Subject(s)
Cannabinoids/pharmacology , Demyelinating Diseases/physiopathology , Lysophosphatidylcholines/pharmacology , Mononeuropathies/physiopathology , Peripheral Nerves/physiopathology , Action Potentials/drug effects , Animals , Behavior, Animal/drug effects , Demyelinating Diseases/chemically induced , Demyelinating Diseases/complications , Disease Models, Animal , Drug Administration Routes , Excitatory Amino Acid Antagonists/pharmacology , Ganglia, Spinal/metabolism , Ganglia, Spinal/pathology , Immunohistochemistry , Mice , Mice, Inbred C57BL , Mononeuropathies/chemically induced , Mononeuropathies/complications , Mononeuropathies/pathology , Nerve Fibers, Myelinated/drug effects , Nerve Fibers, Myelinated/pathology , Neurons, Afferent/drug effects , Neurons, Afferent/pathology , Neurons, Afferent/physiology , Neuropeptide Y/metabolism , Pain/drug therapy , Pain/physiopathology , Peripheral Nerves/drug effects , Peripheral Nerves/pathology , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Receptors, Opioid, mu/agonists , Reflex/drug effects , Sciatic Nerve/drug effects , Sciatic Nerve/pathology , Sciatic Nerve/physiopathology , Sodium Channels/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL